| 申请号 | 申请类型 | 商品名 | 活性成分 | 中文活性成分 | 剂型/给药途径 | 批准日期 | 申请机构 |
|---|---|---|---|---|---|---|---|
| 761224 | BLA | TEZSPIRE | TEZEPELUMAB-EKKO | 泽芦人单抗 | SOLUTION;SUBCUTANEOUS | 2021-12-17 | ASTRAZENECA AB |
| 761223 | BLA | JEMPERLI | DOSTARLIMAB-GXLY | INJECTABLE;INJECTION | 2021-08-17 | GLAXOSMITHKLINE LLC | |
| 761216 | BLA | YUSIMRY | ADALIMUMAB-AQVH | 阿达木单抗 | INJECTABLE;INJECTION | 2021-12-17 | COHERUS BIOSCIENCES INC |
| 761215 | BLA | REZVOGLAR | INSULIN GLARGINE-AGLR | 甘精胰岛素 | INJECTABLE;INJECTION | 2021-12-17 | ELI LILLY CO |
| 761210 | BLA | RYBREVANT | AMIVANTAMAB-VMJW | 埃万妥单抗 | INJECTABLE;INJECTION | 2021-05-21 | JANSSEN BIOTECH |
| 761208 | BLA | TIVDAK | TISOTUMAB VEDOTIN-TFTV | 维汀-替索妥单抗 | INJECTABLE;INJECTION | 2021-09-20 | SEAGEN |
| 761202 | BLA | BYOOVIZ | RANIBIZUMAB-NUNA | 雷珠单抗 | INJECTABLE;INJECTION | 2021-09-17 | SAMSUNG BIOEPIS CO LTD |
| 761201 | BLA | SEMGLEE | INSULIN GLARGINE-YFGN | 甘精胰岛素 | INJECTABLE;INJECTION | 2021-07-28 | MYLAN PHARMS INC |
| 761197 | BLA | SUSVIMO | RANIBIZUMAB | 雷珠单抗 | SOLUTION;INJECTION | 2021-10-22 | GENENTECH INC |
| 761196 | BLA | ZYNLONTA | LONCASTUXIMAB TESIRINE-LPYL | 替朗妥昔单抗 | INJECTABLE;INJECTION | 2021-04-23 | ADC Therapeutics SA |
| 761195 | BLA | VYVGART | EFGARTIGIMOD ALFA | 依伽莫德α | INJECTABLE;INJECTION | 2021-12-17 | ARGENX BV |
| 761194 | BLA | NEXVIAZYME | AVALGLUCOSIDASE ALFA-NGPT | 艾夫糖苷酶α | INJECTABLE;INJECTION | 2021-08-06 | GENZYME CORP |
| 761181 | BLA | EVKEEZA | EVINACUMAB-DGNB | 依维苏单抗 | SOLUTION; INJECTION | 2021-02-11 | REGENERON PHARMACEUTICALS |
| 761180 | BLA | ADBRY | TRALOKINUMAB | 曲洛吉努单抗 | INJECTABLE;INJECTION | 2021-12-27 | LEO PHARMA AS |
| 761179 | BLA | RYLAZE | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | INJECTABLE;INTRAMUSCULAR | 2021-06-30 | JAZZ PHARMS | |
| 761178 | BLA | ADUHELM | ADUCANUMAB-AVWA | 阿度努单抗 | INJECTABLE;INJECTION | 2021-06-07 | BIOGEN INC |
| 761177 | BLA | SKYTROFA | LONAPEGSOMATROPIN-TCGD | 隆培促生长素 | INJECTABLE;INJECTION | 2021-08-25 | ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S |
| 761174 | BLA | JEMPERLI | DOSTARLIMAB-GXLY | INJECTABLE;INJECTION | 2021-04-22 | GLAXOSMITHKLINE | |
| 761172 | BLA | EBANGA | ANSUVIMAB-ZYKL | POWDER;IV (INFUSION) | 2020-12-21 | RIDGEBACK BIOTHERAPEUTICS | |
| 761171 | BLA | DANYELZA | NAXITAMAB-GQGK | 那昔妥单抗 | SOLUTION;INTRAVENOUS | 2020-11-25 | Y-MABS THERAPEUTICS INC |